Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Selah Genomics

Selah Genomics
2006 FOUNDED
M&A STATUS
11-20 EMPLOYEES
Conv. Debt LATEST DEAL TYPE
$450K LATEST DEAL AMOUNT
Description

Provider of genetic diagnostic services intended to offer values to early-stage drug development, clinical trials and regulatory processes in the pharmaceutical industry. The company's genetic diagnostic services use advanced molecular, traditional and cutting edge technologies enabling healthcare providers and the pharmaceutical industry to deliver more personalized treatment and patient monitoring that lead to improved patient outcomes.

Formerly Known As
Lab21, Selah Technologies
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Parent Company
Primary Office
  • 411 University Ridge
  • Suite A
  • Greenville, SC 29601
  • United States

+1 (864) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Selah Genomics’s full profile, request a free trial.

Selah Genomics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Convertible Debt 02-Mar-2016 $450K Completed Generating Revenue
12. Merger/Acquisition 23-Dec-2015 Completed Generating Revenue
11. Merger/Acquisition 17-Apr-2014 000.00 00.000 000.00 Completed Generating Revenue
10. Later Stage VC 28-May-2013 00.000 00.000 00.00 Completed Generating Revenue
9. Buyout/LBO (MBO) 08-Jan-2013 Completed Generating Revenue
8. Merger/Acquisition 31-Dec-2009 00.000 Completed Startup
7. Debt - General 01-Oct-2009 00.000 Completed Startup
6. Grant 20-Mar-2009 00000 00.000 Completed Startup
5. Early Stage VC 17-Mar-2009 $1.84M $5.24M Completed Startup
4. Early Stage VC (Series A) 28-Dec-2008 $3.2M $3.4M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Selah Genomics Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BroadOak Capital Partners Investment Bank Minority 000 0000 000000 0
EKF Diagnostics Holdings VC-Backed Company Majority 000 0000 000000 0
Excalibur Group Holdings Venture Capital Minority 000 0000 000000 0
Kreos Capital Growth/Expansion Minority 000 0000 000000 0
Lab21 Corporation Majority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Selah Genomics Executive Team (6)

Name Title Board
Seat
Contact
Info
Jennifer Lawrence Vice President, Sales & Marketing and Business Development
Jeremy Stuart Ph.D Co-Founder, Senior Vice President and Scientific Operations

4 Former Executives

You’re viewing 2 of 6 executives. Get the full list »